Waters (NYSE:WAT) Stock Unloaded Rep. Thomas H. Kean, Jr.

Representative Thomas H. Kean, Jr. (Republican-New Jersey) recently sold shares of Waters Corporation (NYSE:WAT). In a filing disclosed on March 18th, the Representative disclosed that they had sold between $1,001 and $15,000 in Waters stock on February 13th.

Representative Thomas H. Kean, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Linde (NASDAQ:LIN) on 2/18/2026.
• Purchased $1,001 – $15,000 in shares of First Citizens BancShares (NASDAQ:FCNCA) on 2/5/2026.
• Sold $15,001 – $50,000 in shares of Alphabet (NASDAQ:GOOGL) on 2/5/2026.
• Purchased $1,001 – $15,000 in shares of Abbott Laboratories (NYSE:ABT) on 1/29/2026.
• Sold $15,001 – $50,000 in shares of Stryker (NYSE:SYK) on 1/23/2026.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 1/23/2026.
• Sold $15,001 – $50,000 in shares of Johnson & Johnson (NYSE:JNJ) on 1/23/2026.
• Sold $15,001 – $50,000 in shares of Markel Group (NYSE:MKL) on 1/23/2026.
• Sold $1,001 – $15,000 in shares of General Motors (NYSE:GM) on 1/7/2026.

Waters Price Performance

Shares of NYSE:WAT traded up $0.72 during midday trading on Wednesday, reaching $302.64. 257,016 shares of the company were exchanged, compared to its average volume of 1,098,255. The stock has a market cap of $29.69 billion, a PE ratio of 28.10, a price-to-earnings-growth ratio of 2.08 and a beta of 1.20. The business’s fifty day moving average is $338.89 and its two-hundred day moving average is $351.53. Waters Corporation has a one year low of $275.05 and a one year high of $414.15. The company has a current ratio of 1.73, a quick ratio of 1.27 and a debt-to-equity ratio of 0.37.

Waters (NYSE:WAT) last announced its quarterly earnings results on Monday, February 9th. The medical instruments supplier reported $4.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.50 by $0.03. Waters had a net margin of 20.30% and a return on equity of 34.79%. The company had revenue of $932.36 million for the quarter, compared to the consensus estimate of $928.17 million. During the same period in the previous year, the firm posted $4.10 EPS. Waters’s revenue for the quarter was up 6.9% compared to the same quarter last year. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. As a group, analysts predict that Waters Corporation will post 12.86 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. Wells Fargo & Company reduced their target price on Waters from $415.00 to $355.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 11th. Barclays initiated coverage on Waters in a research note on Tuesday, February 10th. They set an “overweight” rating and a $400.00 price target for the company. Wall Street Zen downgraded Waters from a “buy” rating to a “hold” rating in a research note on Sunday, February 8th. Bank of America decreased their price objective on Waters from $410.00 to $350.00 and set a “neutral” rating on the stock in a report on Tuesday, February 10th. Finally, William Blair started coverage on Waters in a research report on Monday, January 5th. They set an “outperform” rating for the company. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, Waters currently has an average rating of “Moderate Buy” and a consensus price target of $393.84.

Insider Activity at Waters

In other Waters news, Director Wei Jiang purchased 500 shares of Waters stock in a transaction dated Monday, March 16th. The shares were purchased at an average cost of $289.46 per share, for a total transaction of $144,730.00. Following the completion of the acquisition, the director owned 3,441 shares in the company, valued at $996,031.86. This represents a 17.00% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.82% of the company’s stock.

Institutional Investors Weigh In On Waters

Several hedge funds and other institutional investors have recently made changes to their positions in WAT. Mawer Investment Management Ltd. grew its holdings in Waters by 225.5% during the 3rd quarter. Mawer Investment Management Ltd. now owns 1,551,010 shares of the medical instruments supplier’s stock valued at $465,008,000 after purchasing an additional 1,074,449 shares during the last quarter. Alliancebernstein L.P. raised its position in Waters by 31.0% in the 2nd quarter. Alliancebernstein L.P. now owns 4,021,358 shares of the medical instruments supplier’s stock worth $1,403,615,000 after purchasing an additional 950,687 shares during the period. Massachusetts Financial Services Co. MA lifted its stake in Waters by 44.3% in the third quarter. Massachusetts Financial Services Co. MA now owns 2,689,693 shares of the medical instruments supplier’s stock worth $806,397,000 after purchasing an additional 825,723 shares during the last quarter. Norges Bank purchased a new position in shares of Waters during the second quarter valued at approximately $266,384,000. Finally, Veritas Asset Management LLP boosted its position in shares of Waters by 112.3% during the fourth quarter. Veritas Asset Management LLP now owns 1,241,206 shares of the medical instruments supplier’s stock valued at $471,447,000 after buying an additional 656,436 shares during the period. Hedge funds and other institutional investors own 94.01% of the company’s stock.

About Representative Kean

Thomas Kean Jr. (Republican Party) is a member of the U.S. House, representing New Jersey’s 7th Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Kean (Republican Party) is running for re-election to the U.S. House to represent New Jersey’s 7th Congressional District. He declared candidacy for the 2026 election.

Thomas Kean Jr. lives in Westfield, New Jersey. Kean earned a master’s degree from the Tufts University Fletcher School of Law and Diplomacy. His career experience includes working with the Environmental Protection Agency during the George H.W. Bush administration and as an advisor to former U.S. Representative Bob Franks, a firefighter, and an emergency medical technician. Kean has served as the vice president of a fire department.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.